Hormonal and metabolic gender differences in a cohort of myotonic dystrophy type 1 subjects: a retrospective, case–control study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Harper PS (2001) Myotonic dystrophy. Monckton DG, London
Jansen G, Mahadevan M, Amemiya C, Wormskamp N, Segers B, Hendriks W, O’Hoy K, Baird S, Sabourin L, Lennon G (1992) Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs. Nat Genet 1(4):261–266
Udd B, Krahe R (2012) The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol 11(10):891–905
De Antonio M, Dogan C, Hamroun D, Mati M, Zerrouki S, Eymard B, Katsahian S, Bassez G, French A (2016) Unravelling the myotonic dystrophy type 1 clinical spectrum: a sytematic registry-based study with implications for disease clasification. Rev Neurol (Paris) 172(10):572–580
Stokes M, Varughese N, Iannaccone S, Castro D (2019) Clinical and genetic characteristics of childhood-onset myotonic dystrophy. Muscle Nerve 60(6):732–738
Miller JW, Urbinati CR, Teng-Umnuay P, Stenberg MG, Byrne BJ, Thornton C, Swanson MS (2000) Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO 19(17):4439–4448
Taneja KL, McCurrach M, Schalling M, Housman D, Singer RH (1995) Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol 128(6):995–1002
Davis BM, McCurrach ME, Taneja KL, Singer RH, Housman DE (1997) Expansion of a CUG trinucleotide repeat in the 3′-untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc Natll Acad Sci 94:7388–7393
Czubak K, Sedehizadeh S, Kozlowski P, Wojciechowska M (2019) An overview of circular RNAs and their implications in myotonic dystrophy. Int J Mol Sci 20(18):4385. https://doi.org/10.3390/ijms20184385
Mastrogiacomo I, Pagani E, Novelli G, Angelini C, Gennarelli M, Menegazzo E, Bonanni G, Dallapiccola B (1994) Male hypogonadism in myotonic dystrophy is related to (CTG)n triplet mutation. J Endocrinol Invest 17(5):381–383
Vazquez JA, Pinies JA, Martul P, De los Rios A, Gatzambide S, Busturia MA (1990) Hypothalamic-pituitary-testicular function in 70 patients with myotonic dystrophy. J Endocrinol Invest 13(5):375–379
Kaminsky P, Pruna L (2012) A genetic systemic disease: clinical description of type 1 myotonic dystrophy in adults. Rev Med Interne 33(9):514–518
Shieh K, Gilchrist JM, Promrat K (2010) Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy. Muscle Nerve 41(2):197–201
Cruz Gùzman OR, Chávez García AL, Rodríguez-Cruz M (2012) Muscular dystrophies at different ages: metabolic and endocrine alterations. Int J Endocrinol 2012:485376
Roussel MP, Morin M, Gagnon C, Duchesne E (2019) What is known about the effects of exercise or training to reduce skeletal muscle impairments of patients with myotonic dystrophy type 1? A scopimg review. BMC Muscoloskelet Disord 20(1):101
Win AK, Perattur PG, Pulido JS, Pulido CM, Lindor NM (2012) Increased cancer risks in myotonic dystrophy. Mayo Clin Proc 87(2):130–135
Zmuda JM, Cauley JA, Kriska A, Glynn NW, Gutai JP, Kuller LH (1997) Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. Am J Epidemiol 146(8):609–617
Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 86(2):724–731. https://doi.org/10.1210/jcem.86.2.7219
Spaziani M, Mileno B, Rossi F, Granato S, Tahani N, Anzuini A, Lenzi A, Radicioni AF (2018) Endocrine and metabolic evaluation of classic Klinefelter syndrome and high grade aneuploidies of sexual chromosomes with male phenotype: are they different clinical conditions? Eur J Endocrinol 178:1–10
Radicioni AF, Tahani N, Spaziani M, Anzuini A, Piccheri C, Semeraro A, Tarani L, Lenzi A (2013) Reference ranges for thyroid hormones in normal Italian children and adolescents and overweight adolescents. J Endocrinol Investig 36(5):326–330
Russ G, Bigorgne C, Royer B, Rouxel A, Bienvenu-Perrard M (2011) The thyroid imaging reporting and data system (TIRADS) for ultrasound of the thyroid. J Radiol 92(7–8):701–713
Daumerie C, Lannoy N, Squifflet JP, Verellen G, Verellen-Dumoulin C (1994) High CTG repeat number in nodular thyroid tissue from a myotonic dystrophy patient. J Med Genet 31(11):891–892
Van den Beld AW, Visser TJ, Feelders RA, Grobbee DE, Lamberts SW (2005) Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. J Clin Endocrinol Metab 90(12):6403–6409
De Alfieri W, Nisticò F, Borgogni T, Riello F, Cellai F, Mori C, Nante N, Di Bari M (2013) Thyroid hormones as predictors of short- and long-term mortality in very old hospitalized patients. J Gerontol A Biol Sci Med Sci 68(9):1122–1128
Maia AL, Goemann IM, Meyer EL, Wajner SM (2011) Deiodinases: the balance of thyroid hormone: type 1 iodothyronine deiodinase in human physiology and disease. J Endocrinol 209(3):283–297
Pasqualetti G, Calsolaro V, Bernardini S, Linsalata G, Bigazzi R, Caraccio N, Monzani F (2018) Degree of peripheral thyroxin deiodination, frailty, and long-term survival in hospitalized older patients. J Clin Endocrinol Metab 103(5):1867–1876
Emerenziani GP, Izzo G, Vaccaro MG, Quattrone A, Lenzi A, Aversa A (2019) Gender difference and correlation between sexuality, thyroid hormones, cognitive, and physical functions in elderly fit. J Endocrinol Invest 42(6):699–707
Carter JN, Steinbeck KS (1985) Reduced adrenal androgens in patients with myotonic dystrophy. J Clin Endocrinol Metab 60(3):611–614
Johansson Ǻ, Carlström K, Ahrén B, Cederquist K, Krylborg E, Forsberg H, Olsson T (2000) Abnormal cytokine and adrenocortical hormone regulation in myotonic dystrophy. J Clin Endocrinol Metab 85(9):3169–3176
Johansson Ǻ, Andrew R, Forsberg H, Cederquist K, Walker BR, Olsson T (2001) Glucocorticoid metabolism and adrenocortical reactivity to ACTH in myotonic dystrophy. J Clin Endocrinol Metab 86(9):4276–4283
Ørngreen MC, Arlien-Søborg P, Duno M, Hertz JM, Vissing J (2012) Endocrine function in 97 patients with myotonic dystrophy type 1. J Neurol 259(5):912–920
Henriksen OA, Sundsfjord JA, Nyberg-Hansen R (1978) Evaluation of the endocrine functions in dystrophia myotonica. Acta Neurol Scand 58:178–189
May PB, Renny A, Bastek J, Giglio W, Schneider G, Ertel N (1980) Diminished prolactin reserve with myotonic dystrophy. J Endocrinol Invest 3(4):415–418
Canal N, Smirne S, Comi G, Guidobono F, Pecile A, Caviezel F (1982) Study on growth hormone and prolactin secretions in myotonic dystrophy. Acta Neurol Belg 82:178–184
Passeri E, Bugiardini E, Sansone VA, Pizzoccaro A, Fulceri C, Valaperta R, Borgato S, Costa E, Bandera F, Ambrosi B et al (2015) Gonadal failure is associated with visceral adiposity in myotonic dystrophies. Eur J Clin Invest 45(7):702–710
Pizzi A, Fusi S, Forti G, Marconi G (1985) Study of endocrine function in myotonic dystrophy. Ital J Neurol Sci 6(4):457–467
Mastrogiacomo I, Bonanni G, Menegazzo E, Santarossa C, Pagani E, Gennarelli M, Angelini C (1996) Clinical and hormonal aspects of male hypogonadism in myotonic dystrophy. Ital J Neurol Sci 17(1):59–65
Vasquez JA, Pinies JA, Martul P, De los Rios A, Gatzambide S, Busturia MA (1990) Hypotalamic-pituitary-testicular function in 70 patients with Myotonic Dystrophy. J Endocrinol Invest 13:375–379
Lou XY, Nishi Y, Haji M, Antoku Y, Tanaka S, Ikuyama S, Yanase T, Takayanagi R, Nawata H (1994) Reserved Sertoli cell function in the hypogonadic male patients with myotonic dystrophy. Fukuoka Igaku Zasshi 85(5):168–174
Francomano D, Greco EA, Lenzi A, Aversa A (2013) CAG repeat testing of androgen receptor polymorphism: is this necessary for the best clinical management of hypogonadism? J Sex Med 10(10):2373–2381
Kunej T, Teran N, Zorn B, Peterlin B (2004) CTG amplification in the DM1PK gene is not associated with idiopathic male subfertility. Hum Reprod 19(9):2084–2087
Francomano D, Fattorini G, Gianfrilli D, Paoli D, Sgrò P, Radicioni A, Romanelli F, Di Luigi L, Gandini L, Lenzi A, Aversa A (2016) Acute endothelial response to testosterone gel administration in men with severe hypogonadism and its relationship to androgen receptor polymorphism: a pilot study. J Endocrinol Invest 39(3):265–271
Antonini G, Clemenzi A, Bucci E, De Marco E, Morino S, Di Pasquale A, Latino P, Ruga G, Lenzi A, Vanacore N et al (2011) Hypogonadism in DM1 and its relationship to erectile dysfunction. J Neurol 258(7):1247–1253
Matsumura T, Iwahashi H, Funahasci T, Takahashi MP, Saito T, Yasui K, Saito T, Iyama A, Toyooka K, Fujimura H et al (2009) A cross sectional study for glucose intolerance of myotonic distrophy. J Neurol Sci 276:60–65
Dahlqvist JR, Ørngreen MC, Witting N, Vissing J (2015) Endocrine function over time in patients with myotonic dystrophy type 1. Eur J Neurol 22:116–122
Vujnic M, Peric S, Popovic S, Raseta N, Ralic V, Dobricic V, Novakovic I, Rakocevic-Stojanovic V (2015) Metabolic syndrome in patients with Myotonic dystrophy type 1. Muscle Nerve 2(2):273–277
Kalafateli M, Triantos C, Tsamandas A, Kounadis G, Labropoulou-Karatza C (2012) Abnormal liver function tests in a patient with myotonic dystrophy type 1. Ann Hepatol 11:130–133
Achiron A, Barak Y, Magal N, Shohat M, Cohen M, Barar R, Gadoth N (1998) Abnormal liver tests results in myotonic dystrophy. J Clin Gastroenterol 26:292–295
Heatwole C, Miller J, Martens B, Moxley R (2006) Laboratoty abnormalities in ambulatory patients with myotonic dystrophy type 1. Arch Neurol 63:1149–1153